vs
亚什兰（ASH）与杜比实验室（DLB）财务数据对比。点击上方公司名可切换其他公司
杜比实验室的季度营收约是亚什兰的1.0倍（$395.6M vs $386.0M），杜比实验室净利率更高（24.0% vs -3.1%，领先27.1%），杜比实验室同比增速更快（7.1% vs -4.7%），过去两年杜比实验室的营收复合增速更高（13.9% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
杜比实验室是一家美国科技企业，专注于音频降噪、音频编码压缩、空间音频及高动态范围（HDR）影像等技术的研发，旗下技术广泛授权给全球各地的消费电子制造商使用，助力终端产品为用户带来更出色的视听体验。
ASH vs DLB — 直观对比
营收规模更大
DLB
是对方的1.0倍
$386.0M
营收增速更快
DLB
高出11.7%
-4.7%
净利率更高
DLB
高出27.1%
-3.1%
两年增速更快
DLB
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $395.6M |
| 净利润 | $-12.0M | $94.9M |
| 毛利率 | 27.2% | 88.7% |
| 营业利润率 | -1.6% | 28.5% |
| 净利率 | -3.1% | 24.0% |
| 营收同比 | -4.7% | 7.1% |
| 净利润同比 | 92.7% | 3.4% |
| 每股收益（稀释后） | $-0.26 | $0.99 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHDLB
| Q2 26 | — | $395.6M | ||
| Q1 26 | — | $346.7M | ||
| Q4 25 | $386.0M | $346.7M | ||
| Q3 25 | $477.0M | $307.0M | ||
| Q2 25 | $463.0M | $315.5M | ||
| Q1 25 | $479.0M | $369.6M | ||
| Q4 24 | $405.0M | $357.0M | ||
| Q3 24 | $521.0M | $304.8M |
净利润ASHDLB
| Q2 26 | — | $94.9M | ||
| Q1 26 | — | $53.3M | ||
| Q4 25 | $-12.0M | $53.3M | ||
| Q3 25 | $31.0M | $49.3M | ||
| Q2 25 | $-742.0M | $46.1M | ||
| Q1 25 | $31.0M | $91.8M | ||
| Q4 24 | $-165.0M | $67.8M | ||
| Q3 24 | $17.0M | $58.6M |
毛利率ASHDLB
| Q2 26 | — | 88.7% | ||
| Q1 26 | — | 87.5% | ||
| Q4 25 | 27.2% | 87.5% | ||
| Q3 25 | 33.3% | 87.1% | ||
| Q2 25 | 28.5% | 86.1% | ||
| Q1 25 | 30.7% | 90.3% | ||
| Q4 24 | 27.4% | 88.6% | ||
| Q3 24 | 33.2% | 88.8% |
营业利润率ASHDLB
| Q2 26 | — | 28.5% | ||
| Q1 26 | — | 17.9% | ||
| Q4 25 | -1.6% | 17.9% | ||
| Q3 25 | 12.8% | 9.7% | ||
| Q2 25 | -152.9% | 15.1% | ||
| Q1 25 | 10.6% | 29.2% | ||
| Q4 24 | -44.2% | 22.4% | ||
| Q3 24 | 6.1% | 15.2% |
净利率ASHDLB
| Q2 26 | — | 24.0% | ||
| Q1 26 | — | 15.4% | ||
| Q4 25 | -3.1% | 15.4% | ||
| Q3 25 | 6.5% | 16.1% | ||
| Q2 25 | -160.3% | 14.6% | ||
| Q1 25 | 6.5% | 24.8% | ||
| Q4 24 | -40.7% | 19.0% | ||
| Q3 24 | 3.3% | 19.2% |
每股收益（稀释后）ASHDLB
| Q2 26 | — | $0.99 | ||
| Q1 26 | — | $0.55 | ||
| Q4 25 | $-0.26 | $0.55 | ||
| Q3 25 | $0.83 | $0.50 | ||
| Q2 25 | $-16.21 | $0.48 | ||
| Q1 25 | $0.65 | $0.94 | ||
| Q4 24 | $-3.50 | $0.70 | ||
| Q3 24 | $0.34 | $0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $594.7M |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $1.9B | $2.6B |
| 总资产 | $4.5B | $3.2B |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资ASHDLB
| Q2 26 | — | $594.7M | ||
| Q1 26 | — | $644.6M | ||
| Q4 25 | $304.0M | $644.6M | ||
| Q3 25 | $215.0M | $702.6M | ||
| Q2 25 | $207.0M | $699.3M | ||
| Q1 25 | $168.0M | $626.6M | ||
| Q4 24 | $219.0M | $520.8M | ||
| Q3 24 | $300.0M | $482.0M |
总债务ASHDLB
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — |
股东权益ASHDLB
| Q2 26 | — | $2.6B | ||
| Q1 26 | — | $2.6B | ||
| Q4 25 | $1.9B | $2.6B | ||
| Q3 25 | $1.9B | $2.6B | ||
| Q2 25 | $1.9B | $2.6B | ||
| Q1 25 | $2.6B | $2.6B | ||
| Q4 24 | $2.6B | $2.5B | ||
| Q3 24 | $2.9B | $2.5B |
总资产ASHDLB
| Q2 26 | — | $3.2B | ||
| Q1 26 | — | $3.2B | ||
| Q4 25 | $4.5B | $3.2B | ||
| Q3 25 | $4.6B | $3.2B | ||
| Q2 25 | $4.6B | $3.2B | ||
| Q1 25 | $5.2B | $3.2B | ||
| Q4 24 | $5.2B | $3.2B | ||
| Q3 24 | $5.6B | $3.1B |
负债/权益比ASHDLB
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.51× | — | ||
| Q3 24 | 0.47× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $147.3M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | — |
| 自由现金流率自由现金流/营收 | 28.8% | — |
| 资本支出强度资本支出/营收 | 3.6% | — |
| 现金转化率经营现金流/净利润 | — | 1.55× |
| 过去12个月自由现金流最近4个季度 | $200.0M | — |
8季度趋势，按日历期对齐
经营现金流ASHDLB
| Q2 26 | — | $147.3M | ||
| Q1 26 | — | $54.8M | ||
| Q4 25 | $125.0M | $54.8M | ||
| Q3 25 | $40.0M | $472.2M | ||
| Q2 25 | $115.0M | $67.7M | ||
| Q1 25 | $9.0M | $174.9M | ||
| Q4 24 | $-30.0M | $106.8M | ||
| Q3 24 | $80.0M | $327.3M |
自由现金流ASHDLB
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $111.0M | $50.2M | ||
| Q3 25 | $6.0M | $435.9M | ||
| Q2 25 | $95.0M | $61.3M | ||
| Q1 25 | $-12.0M | $168.0M | ||
| Q4 24 | $-53.0M | $100.0M | ||
| Q3 24 | $42.0M | $297.2M |
自由现金流率ASHDLB
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 28.8% | 14.5% | ||
| Q3 25 | 1.3% | 142.0% | ||
| Q2 25 | 20.5% | 19.4% | ||
| Q1 25 | -2.5% | 45.5% | ||
| Q4 24 | -13.1% | 28.0% | ||
| Q3 24 | 8.1% | 97.5% |
资本支出强度ASHDLB
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | 1.3% | ||
| Q3 25 | 7.1% | 11.8% | ||
| Q2 25 | 4.3% | 2.0% | ||
| Q1 25 | 4.4% | 1.9% | ||
| Q4 24 | 5.7% | 1.9% | ||
| Q3 24 | 7.3% | 9.8% |
现金转化率ASHDLB
| Q2 26 | — | 1.55× | ||
| Q1 26 | — | 1.03× | ||
| Q4 25 | — | 1.03× | ||
| Q3 25 | 1.29× | 9.57× | ||
| Q2 25 | — | 1.47× | ||
| Q1 25 | 0.29× | 1.91× | ||
| Q4 24 | — | 1.57× | ||
| Q3 24 | 4.71× | 5.59× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
DLB
| Licensing | $372.2M | 94% |
| Products and services | $23.4M | 6% |
